News

News

  1. Published: 12 Oct 2020

    Angelini Pharma broadens its HPAPI CDMO capabilities

    Responding to the rising number of custom HPAPIs demand, Angelini Fine Chemicals is expanding its HPAPI capacity at its Aprilia,Italy plant site. With over 50 years of CDMO experience, Angelini Fine Chemicals is at the forefront of chemical development and cGMP manufacturing of Adv. IMs, APIs and HPAPIs to serving brand pharmaceutica industry.